HCW Biologics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $6 | $5 | $394 | $426 |
Gross Profit | 1 | 1 | -603 | 85 |
EBITDA | -3,464 | -1,965 | -2,442 | -3,550 |
EBIT | -2,384 | -3,125 | -3,678 | |
Net Income | -12,081 | -2,196 | -3,373 | -3,902 |
Net Change In Cash | 6 | 5 | 394 | 426 |
Free Cash Flow | -3,282 | -3,513 | -2,948 | -2,963 |
Cash | 2,438 | 1,107 | 4,674 | 998 |
Basic Shares | 1,780 | 44,675 | 38,793 | 37,823 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $2,566 | $2,841 | $6,722 | $4,099 |
Gross Profit | 959 | 560 | 2,586 | -543 |
EBITDA | -27,680 | -23,576 | -14,184 | -12,824 |
EBIT | -28,865 | -24,711 | -14,774 | -13,367 |
Net Income | -30,023 | -24,994 | -14,722 | -12,357 |
Net Change In Cash | 2,566 | 2,841 | 6,722 | 4,099 |
Cost of Revenue | 10,595 | |||
Free Cash Flow | -14,489 | -28,716 | -20,661 | -11,022 |
Cash | 4,674 | 3,595 | 22,326 | 11,730 |
Basic Shares | 38,793 | 35,929 | 35,822 | 35,768 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$6.79 |
2025-03-31 | -$1.97 |
2024-12-31 | -$3.20 |
2024-09-30 | -$4 |
